Gerresheimer's Survival Hinges on Creditors as Accounting Scandal Widens

German packaging firm Gerresheimer faces collapse after loan default and major accounting violations, halting reporting and forcing asset sales as legal probes expand.

The immediate fate of German packaging specialist Gerresheimer now rests with its banks. The company is in technical default on its loans after failing to produce audited financial statements, forcing urgent negotiations with creditors to extend deadlines and prevent a collapse of its vital credit lines. This liquidity crisis is compounded by its formal expulsion from the SDAX index, which took effect Friday and triggered selling pressure from index-tracking funds.

At the heart of the turmoil are systematic accounting violations. The company improperly recognized revenue through so-called "bill-and-hold" agreements, booking sales before goods were delivered to customers. This led to incorrectly stated revenue of approximately 35 million euros and an overstated adjusted EBITDA by about 24 million euros. The financial regulator BaFin has significantly expanded its investigation, now scrutinizing falsely reported lease liabilities of 65.5 million euros and incorrect useful lives assigned to capitalized development costs totaling 29.4 million euros.

The scandal has ensnared the company's auditor. Germany's audit oversight body, APAS, initiated a professional misconduct procedure against KPMG on April 8. The firm issued an unqualified audit opinion on the 2024 financial statements despite the embedded systematic errors. To untangle the mess, Grant Thornton has been commissioned to conduct a forensic special audit. A certified annual report is not expected until June 2026 at the earliest.

With its financials in limbo, Gerresheimer has halted all regular reporting. The release of its first-quarter report and the annual shareholder meeting have been postponed indefinitely. To generate urgent cash, management is pulling the emergency brake. The US drug packaging division Centor, which last carried a book value of 292 million euros, is up for sale. Concurrently, the company will shutter its Chicago Heights plant by the end of 2026.

Legal repercussions are mounting. The German shareholder association DSW is preparing damages lawsuits against former CEO Dietmar Siemssen and ex-CFO Bernd Metzner, based on an existing expert report. The allegations concern misvaluations of goodwill worth 676 million euros and technology assets in the Advanced Technologies division with a book value of around 196.5 million euros. The audit committee of the supervisory board is also facing legal scrutiny.

Amid the chaos, the stock trades near its annual low at around 17 euros, reflecting a crushing loss of over 68 percent in the past twelve months. Some institutional investors, including Deka Investment and the CastleKnight Master Fund, have recently established new positions. Market speculation also persists about takeover interest from US conglomerate Silgan Holdings, which Reuters reported is considering an offer of 41 euros per share. However, the absence of audited books currently blocks any concrete acquisition scenarios by external parties.

For now, the market is left without a reliable basis for valuation. Gerresheimer's short-term survival and its stock price trajectory depend almost entirely on whether its banks grant the requested extensions and maintain their credit facilities.